pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

Arsenal Biosciences Inc

updated 2mo ago
Website ↗
community read0 votes
pipeline
2
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0

Pipeline(2)

pipeline depth2 products
Phase 1: 1Phase 2: 1
1Phase 11Phase 2
Phase 2
AB-2100
Metastatic Renal Cell Carcinoma
Phase 1
AB-1015
Epithelial Ovarian Cancer

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →
🐶 Hiring Signal
No open roles indexed yet — view Arsenal Biosciences Inc jobs →

News

  • August biopharma layoffs impact just over 500, down 90% year over year
    Last month, biotech and pharma companies making or planning workforce cuts included three whose reductions will more than halve their workforces. Blueprint Medicines’ layoffs will affect the most e…
    biospace · 22d ago
  • Luma locks down 15-year, $410M fund for life science investments
    Luma Group announced the final close of its inaugural life sciences venture capital fund totaling $410 million.
    fiercebiotech · 23d ago
  • Arsenal Biosciences cuts ‘majority’ of staff in move to in vivo CAR-T
    Roughly a year after shedding half of its workforce, Arsenal Biosciences is trimming its headcount again by letting go of “the majority” of its staffers as a result of a pivot into in vivo CAR-T ...
    endpoints · 1mo ago
  • ArsenalBio sacrifices ‘majority’ of staff in pivot to in vivo CAR T
    After downsizing by 50% last year, Arsenal Biosciences is again laying off employees. This time, 99 people are getting cut as part of a strategic shift to focus the company’s R&D efforts on in vivo…
    biospace · 1mo ago
  • ArsenalBio sheds most of staff in pivot to in vivo CAR-T
    About a year after halving its staff in a clinical push, Arsenal Biosciences is now making a hard pivot that involves laying off most of its employees and seeking out new homes for its assets.
    fiercebiotech · 1mo ago
  • Biotech industry leaders file brief backing FDA against ‘malicious’ mifepristone challenge
    A group of 61 biopharma companies, executives and investors has filed an amicus brief in support of the FDA in an ongoing case brought by Louisiana meant to remove access to the abortion pill mifep…
    fiercebiotech · 2mo ago
identifiers
source
globaldata
top tags
Oncology2
mentioned in
6news items
entity-linker matched

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?